General Dynamics Information Technology Awarded $241 Million Multi-Cloud Contract by Centers for Medicare and Medicaid Services

General Dynamics Information Technology Awarded $241 Million Multi-Cloud Contract by Centers for Medicare and Medicaid Services

General Dynamics Information Technology Awarded $241 Million Multi-Cloud Contract by Centers for Medicare and Medicaid Services

GDIT selected to evolve one of the largest public clouds in the federal government

PR Newswire

FALLS CHURCH, Va., Nov. 25, 2020

FALLS CHURCH, Va., Nov. 25, 2020 /PRNewswire/ —¬†General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE:GD), announced today it has been awarded a new contract by the Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) to provide cloud services and software tools. The Cloud Products and Tool (CPT) task order holds a total estimated value of $241 million, on a one-year base period with three one-year options.

GDIT will procure cloud services and implement a mature multi-cloud environment designed to deliver critical healthcare services to tens of

Read More

Medicare Proposes Expanding Coverage of CGMs

WASHINGTON — Advocates for patients with diabetes are applauding a proposed rule announced Tuesday by the Centers for Medicare & Medicaid Services (CMS) that would expand coverage for continuous glucose monitors (CGMs).

“We appreciate CMS’ recognition that many of the rules limiting access for patients to CGMs are without clinical merit and limit access for patients who need them, especially lower-income Americans,” Laura Friedman, vice president for payment policy at the American Diabetes Association (ADA), in Arlington, Virginia, said in a statement. “We are eager to continue to work with CMS to bring down barriers to technology access, particularly for people with diabetes who have no other way to get this important diabetes management device if their insurance will not cover it.”

Currently, CMS “only covers therapeutic CGMs or those approved by the FDA for use in making diabetes treatment decisions, such as changing one’s diet or insulin dosage based

Read More